Like MDDX

closed 11/6/2017 via PR Web

BioClinica, Inc., acquired MDDX

See 567 Comparable Transactions
synopsis: Bioclinica, a specialty clinical trials services and technology provider, has acquired MDDX, a developer of tools that have been used by researchers in dozens of global research trials. MDDX has created the most advanced cloud research image management platform that provides a private, searchable online image repository with a 20-year lifespan.
buyer parent: Cinven
buyer: BioClinica, Inc.
Bioclinica is a specialty services provider that utilizes expertise and technology to create clarity in the clinical trial process. Bioclinica is organized into three business segments to deliver focused service and multifaceted technologies. "
 target: MDDX
MDDX has developed nearly a dozen tools that have been used by thousands of researchers in dozens of global research trials. The company has created the most advanced cloud research image management platform that provides a private, searchable online image repository with a 20-year lifespan.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/9/2010 via BusinessWire

Orion Healthcare Ventures LLC, acquired Aspyra, Inc.

See 508 Comparable Transactions
synopsis: Aspyra announced the completion of a transaction in which the assets of Aspyra, Inc. have been acquired by Orion Healthcare Ventures LLC which will continue operations under the Aspyra name. Aspyra is a global provider of Health Care Information Technology (HCIT) solutions and services.
buyer: Orion Healthcare Ventures LLC
Orion Healthcare Ventures LLC is a closely held investment firm with a focus on HCIT enterprises that show a strong potential for future growth. "
 target: Aspyra, Inc.
Aspyra specializes in delivering flexible and robust workflow solutions for both the imaging and laboratory marketplaces. Its imaging applications includes Radiology Information Systems (RIS) for hospitals and multi-specialty clinics, imaging departments and centers and orthopaedic environments.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/5/2020 via PR Newswire

Ambra Health, acquired Perspectum

See 780 Comparable Transactions
synopsis: Ambra Health, a medical data and image management SaaS company, has acquired Perspectum, a medical imaging company that discovers, develops, and commercializes innovative solutions for the identification and monitoring of metabolic disease and cancer, delivered through software-as-a-service (SaaS).
buyer: Ambra Health
Ambra Health is a medical data and image management SaaS company. Intuitive, flexible, scalable and highly interoperable, the Ambra cloud platform is designed to serve as the backbone of imaging innovation and progress for healthcare providers. "
 target: Perspectum
Perspectum is a medical imaging company that discovers, develops, and commercializes innovative solutions for the identification and monitoring of metabolic disease and cancer, delivered through software-as-a-service (SaaS).
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/23/2020 via PR Newswire

HgCapital, will acquire Intelerad Medical Systems, Inc.

See 927 Comparable Transactions
synopsis: Novacap, the Canadian-based private equity firm, announced that it has entered into a definitive agreement for the sale of a majority stake in Intelerad Medical Systems, a global provider of medical imaging software and enterprise workflow solutions to Hg, a U.K.-based private equity firm specialized in software and service businesses.
buyer: HgCapital
Hg is a European investor in software and services businesses, with increasing global presence. Hg is a specialist investor, committed to building businesses that change the way people do business, through deep sector specialisation and dedicated operational support. "
 target parent: Novacap Investments Inc.
target: Intelerad Medical Systems, Inc.
Montreal-based Intelerad is a medical imaging software provider that specialises in diagnostic viewing, reporting, and collaboration solutions. The company serves over 300 healthcare organizations around the world, with a strength in radiology groups, imaging centers, clinics, and reading groups.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/29/2019 via Company Press Release

CSAM Health AS, will acquire Kibi AB

See 805 Comparable Transactions
synopsis: CSAM announced that it has entered into an agreement to acquire KIBI – a medical diagnostics and documentation company. KIBI is one of relatively few in the Nordics that addresses both DICOM and non-DICOM formats, with full integration of all medical imaging components with various electronic patient record (EPR) systems.
buyer: CSAM Health AS
CSAM is a leading Nordic niche player in the specialised eHealth market with a unique blend of best-in-class innovative technology, and outstanding human skills. Their diverse portfolio of software solutions enables healthcare providers to access relevant clinical information at the point of care. "
 target: Kibi AB
KIBI is an eHealth solutions leader within medical documentation, ECG and medical imaging. They are one of a few in the Nordics that addresses both DICOM (Digital Imaging and Communications in Medicine) and non-DICOM formats. More than 100 Nordic hospitals and healthcare centres use their solutions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/29/2016 via Company Press Release

MedStreaming, LLC, acquired M2S

See 1063 Comparable Transactions
synopsis: Medstreaming, a leading provider of innovative healthcare cardiovascular and radiology workflow software solutions, announced the acquisition of M2S, a leading provider of registry software technology designed for healthcare quality improvement.
buyer: MedStreaming, LLC
Medstreaming is a provider of innovative healthcare cardiovascular and radiology workflow software solutions. Since 2006, Medstreaming has become a leader in delivering specialty-based workflow applications that function as a “best of breed” application for over 20 different clinical specialties. "
 target parent: Altaris Capital Partners
target: M2S
M2S, Inc. provides medical image, data management, and and outcomes analysis services for the improvement of patient outcomes. It offers image management solutions to allow customers to collect, view, and manage imaging data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/26/2015 via GlobeNewswire

Merge Healthcare Incorporated, acquired DR Systems

See 777 Comparable Transactions
synopsis: Merge Healthcare acquired DR Systems, a privately held San Diego-based company with a strong reputation for customer satisfaction in medical imaging information systems. The combined entities provide an unprecedented array of highly rated healthcare information technology products.
buyer: Merge Healthcare Incorporated (MRGE:$227.59)
Merge is a leading provider of innovative enterprise imaging, interoperability and clinical systems that seek to advance healthcare. Merge's enterprise and cloud-based technologies for image intensive specialties provide access to any image, anywhere, any time. "
 target: DR Systems
DR Systems is a privately held San Diego-based company with a strong reputation for customer satisfaction in medical imaging information systems. DR Systems was founded in 1992 by entrepreneurial practicing physicians with the goal of bringing film-based radiology into the digital age.
price ($mm)[EV]
$76 [$61]
rev ($mm)
$43
EBITDA ($mm)
$10
EV / rev
1.4x
EV / EBITDA
5.8x
closed 6/6/2011 via BusinessWire

ISS Solutions, acquired STATServices

See 345 Comparable Transactions
synopsis: ISS Solutions announced the acquisition of the Strategic Asset Technology Services (STATServices) Division of medical technology company XRI®. STATServices provides healthcare institutions with comprehensive clinical and diagnostic imaging equipment service and asset management programs.
buyer parent: Geisinger Health System
buyer: ISS Solutions
ISS Solutions, a Geisinger Health System company headquartered in Langhorne, Pennsylvania, provides specialized technology lifecycle management solutions to healthcare, government, education, and commercial clients throughout the United States. "
 target parent: XRI
target: STATServices
STATServices provides healthcare institutions with comprehensive clinical and diagnostic imaging equipment service and asset management programs ranging from staffing and equipping a full in-house biomedical department to supplying planned maintenance and/or service on an as-needed basis.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/10/2018 via Company Press Release

Hitachi Healthcare Americas Corporation, will acquire Vidistar, LLC

See 770 Comparable Transactions
synopsis: Hitachi Healthcare Americas Corporation, a leading provider of diagnostic imaging equipment, will acquire VidiStar, LLC, a provider of a web-based diagnostic viewer and patented structured reporting solution for medical imaging and clinical decision support.
buyer parent: Hitachi, Ltd.
buyer: Hitachi Healthcare Americas Corporation
Hitachi Healthcare Americas Corporation, a wholly owned subsidiary of Hitachi, Ltd., offers a broad range of diagnostic imaging equipment including MRI, CT and Ultrasound. Hitachi’s MRI, CT and Ultrasound technologies provide speed, comfort and quality for both physicians and patients alike. "
 target: Vidistar, LLC
VidiStar, LLC provides a web-based diagnostic viewer and patented structured reporting solution for medical imaging and clinical decision support. VidiStar allows physicians and healthcare providers to read and interpret diagnostic studies over the internet for timely interpretation.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/5/2017 via Company Press Release

Philips Electronics NV, acquired Forcare BV

See 672 Comparable Transactions
synopsis: Royal Philips, a global leader in health technology, has acquired Forcare, a leading innovator in open-standards-based interoperability software solutions for fast and flawless data flows between medical systems and information sources at the departmental and enterprise levels, as well as Health Information Exchanges across health systems.
buyer: Philips Electronics NV (ENXTAM:PHIA:$20,876.84)
Based in the Netherlands, Philips is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. "
 target: Forcare BV
Forcare is a leading innovator in open-standards-based interoperability software for fast and flawless data flows between medical systems and information sources. Forcare builds bridges between medical systems and people with software that seamlessly links patient data from various sources.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/30/2019 via BusinessWire

Francisco Partners Management LLC, will acquire Orchard Software Corporation

See 1566 Comparable Transactions
synopsis: Francisco Partners, a leading technology-focused private equity firm, will acquire Orchard Software Corporation, a privately owned company specializing in developing and supporting award-winning Laboratory Information Systems that enhance clinical and pathology laboratory workflow, as well as support laboratory outreach and point-of-care testing.
buyer: Francisco Partners Management LLC
Francisco Partners is a leading global private equity firm that specializes in investments in technology and technology-enabled businesses. They have invested in over 200 technology companies, making them one of the most active and longstanding investors in the technology industry. "
 target: Orchard Software Corporation
Orchard Software is a leader in the laboratory information system industry and offers a variety of laboratory system solutions. Orchard's products are used by physician groups, clinics, hospitals, independent reference labs, student health centers, veterinary labs, and public health organizations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/18/2018 via BNC Analysis

First Foundry, acquired Aces Health

See 599 Comparable Transactions
synopsis: Atlanta-based clinical trial platform Aces Health has been acquired by West Coast venture development firm, First Foundry. Aces, which was founded in 2014, automates patient engagement and data collection during clinical research trials. Aces is rebranding to Dedo, a word that means “data” in Greek.
buyer: First Foundry
First Foundry is part venture capital firm, research incubator, and software development agency. They often help high-potential startup companies in exchange for equity. Their portfolio largely consists of companies and projects in the gaming space, with a few companies in the healthcare vertical. "
 target: Aces Health
Aces automates patient engagement and data collection during clinical research trials. The mobile platform connects to medical and tracking devices ranging from connected blood pressure cuffs to fitness wearables, collects all the patient data to deliver to researchers and providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/10/2018 via Company Press Release

Nexus AG, acquired Medhub sp. z o.o.

See 608 Comparable Transactions
synopsis: NEXUS AG acquired 55% of the shares in MedHub, based in Poznan, Poland. MedHub is one of the top 3 providers of medical software in Poland. MedHub is a recognized leader in electronic patient records, including pharmacy and laboratory solutions.
buyer: Nexus AG (XTRA:NXU:$168.00)
NEXUS AG is a software provider specializing in e-health solutions. NEXUS software helps hospitals, psychiatric clinics and rehabilitation clinics to increase the efficiency and safety of treating patients. "
 target: Medhub sp. z o.o.
MedHub, based in Poznan, Poland is one of the top 3 providers of medical software in Poland. MedHub is a recognized leader in electronic patient records, including pharmacy and laboratory solutions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/19/2013 via BusinessWire

Liaison Technologies, acquired Ignis Systems Corporation

See 585 Comparable Transactions
synopsis: Liaison Technologies, a global provider of secure cloud-based integration and data management services and solutions, announced it has acquired Ignis Systems, a leading provider of clinical data integration solutions for health laboratory and radiology orders and results.
buyer: Liaison Technologies
Liaison Technologies is a global integration and data management company providing unique and high-value solutions to securely move, transform and manage business information on-premise or in the cloud. "
 target: Ignis Systems Corporation
Ignis Systems improves the quality of patient care by connecting the clinic with the outside world. The company's simple, proven solutions integrate with clinical workflows to give doctors better information, make life easier for everyone in the clinic, and improve efficiency and profitability.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/9/2012 via PR Newswire

ERT, acquired invivodata, Inc.

See 618 Comparable Transactions
synopsis: ERT, a global technology-driven provider of health outcomes services to biopharmaceutical sponsors and contract research organizations (CROs), announced the acquisition of invivodata, Inc, a leading provider of electronic Patient Reported Outcomes (ePRO) solutions and Consulting services, based in Pittsburgh, PA.
buyer parent: Genstar Capital LLC
buyer: ERT
ERT is a global technology-driven provider of health outcomes research services and customizable medical devices supporting biopharmaceutical sponsors and contract research organizations to achieve their drug development and healthcare objectives. "
 target: invivodata, Inc.
invivodata is a fully-integrated Clinical Outcome Assessments organization delivering regulatory-proven strategic consulting and practical electronic solutions to biopharmaceutical companies who depend upon patient-centered research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/17/2014 via BNC Analysis

Telstra Health, acquired Cloud 9 Software

See 864 Comparable Transactions
synopsis: Telstra Health has built on its ambition to become a leading provider of integrated eHealth solutions by acquiring the assets of Australian based eHealth cloud software developer Cloud9. Cloud9 is a global provider of next-generation connected healthcare solutions used by thousands of healthcare providers across the Asia Pacific region.
buyer parent: Telstra Corporation Limited
buyer: Telstra Health (ASX:TLS:$20,666.75)
Telstra Health is a leading provider of eHealth solutions with the ambition to create a better health system for patients, providers and funders. Telstra Health is a business division of Telstra Corporation, Australia’s largest telecommunication company. "
 target: Cloud 9 Software
Cloud9 is a global provider of next-generation connected healthcare solutions used by thousands of healthcare providers across the Asia Pacific region. Cloud9’s next generation hospital information system (C-HIS) offers a comprehensive suite of feature rich clinical ancillary applications.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/22/2013 via BusinessWire

XIFIN, Inc., acquired PathCentral, Inc.

See 1457 Comparable Transactions
synopsis: XIFIN, Inc., the financial cloud computing company whose platform is revolutionizing the business of healthcare diagnostics from patient to payment, announced that it has acquired the product and service assets and related intellectual property of PathCentral, a technology company dedicated to the success of the worldwide pathology community.
buyer: XIFIN, Inc.
XIFIN is a next-generation, cloud-based, revenue cycle management system that maximizes cash collection, improves operational efficiency, increases profit and reduces the risks associated with regulatory compliance with a compelling return on investment and rapid time-to-value. "
 target: PathCentral, Inc.
PathCentral is a California-based provider of a fully integrated, web-based enterprise software platform designed specifically for community pathologists. Created by a team of pathologists and industry executives, PathCentral’s solution integrates all aspects of a pathology practice’s business.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/10/2013 via BusinessWire

TherapyEdge, acquired Evivar Medical Pty. Ltd.

See 506 Comparable Transactions
synopsis: TherapyEdge (Advanced Biological Laboratories) announced the acquisition of all the assets of Evivar Medical Pty Ltd. This includes Evivar’s Hepatitis B and C virus web-based decision support tools for clinicians and the associated viral genome analysis systems, intellectual property portfolio & all related commercial arrangements and operations.
buyer: TherapyEdge
Advanced Biological Laboratories (ABL), S.A. has a comprehensive suite of healthcare management tools, including TherapyEdge®, ViroScore®, DeepChek® and VisibleChek®, which are used for data and patient management, monitoring and personalized reporting applications. "
 target: Evivar Medical Pty. Ltd.
Evivar provides accurate and timely therapy management for Hepatitis B & C patients, respectively through its SeqHepB and SeqhepC programmes (web-based decision support tools) to assist physicians to optimise and individualise the treatment schedule of patients with chronic hepatitis.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/6/2018 via BusinessWire

Premier, Inc., will acquire Stanson Health

See 777 Comparable Transactions
synopsis: Premier Inc., a leading healthcare improvement company, signed an agreement to acquire Stanson Health, a software-as-a-service-based provider of clinical decision support tools that are integrated directly into the electronic health record workflow, providing real-time, patient-specific best practices at the point of care.
buyer: Premier, Inc. (PINC:$1,217.64)
Premier, Inc. is a leading healthcare improvement company, uniting an alliance of approximately 3,600 U.S. hospitals and 120,000 other providers to transform healthcare. Premier enables better care and outcomes at a lower cost. "
 target: Stanson Health
Stanson Health is a leader in developing next-generation Clinical Decision Support solutions. Stanson provides EHR-integrated, actionable real-time interventions optimized for use in the provider's clinical workflow.
price ($mm)
$52
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/21/2011 via Company Press Release

athenahealth, Inc., will acquire Proxsys, LLC

See 777 Comparable Transactions
synopsis: athenahealth, Inc., a leading provider of cloud-based practice management, electronic health record (EHR), and patient communication services to medical groups, announced that it has signed a definitive agreement to acquire Proxsys, LLC, a leading provider of cloud-based care coordination services between physicians and hospitals.
buyer: athenahealth, Inc. (ATHN:$1,311.40)
athenahealth, Inc. is a leading provider of cloud-based business services for physician practices. athenahealth's service offerings are based on proprietary web-native practice management and electronic health record (EHR) software. "
 target: Proxsys, LLC
Proxsys, LLC is a provider of cloud-based care coordination services between physicians and hospitals. It partners with dozens of hospitals across as many different states to provide streamlined admitting services to health care facilities and their patients.
price ($mm)
$28
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
Pages:  
closed 11/6/2017 via PR Web

BioClinica, Inc., acquired MDDX

See 567 Comparable Transactions
synopsis: Bioclinica, a specialty clinical trials services and technology provider, has acquired MDDX, a developer of tools that have been used by researchers in dozens of global research trials. MDDX has created the most advanced cloud research image management platform that provides a private, searchable online image repository with a 20-year lifespan.
buyer parent: Cinven
buyer: BioClinica, Inc.
Bioclinica is a specialty services provider that utilizes expertise and technology to create clarity in the clinical trial process. Bioclinica is organized into three business segments to deliver focused service and multifaceted technologies. "
 target: MDDX
MDDX has developed nearly a dozen tools that have been used by thousands of researchers in dozens of global research trials. The company has created the most advanced cloud research image management platform that provides a private, searchable online image repository with a 20-year lifespan.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/6/2017 via PR Web

BioClinica, Inc., acquired MDDX

See 567 Comparable Transactions
synopsis: Bioclinica, a specialty clinical trials services and technology provider, has acquired MDDX, a developer of tools that have been used by researchers in dozens of global research trials. MDDX has created the most advanced cloud research image management platform that provides a private, searchable online image repository with a 20-year lifespan.
buyer parent: Cinven
buyer: BioClinica, Inc.
Bioclinica is a specialty services provider that utilizes expertise and technology to create clarity in the clinical trial process. Bioclinica is organized into three business segments to deliver focused service and multifaceted technologies. "
 target: MDDX
MDDX has developed nearly a dozen tools that have been used by thousands of researchers in dozens of global research trials. The company has created the most advanced cloud research image management platform that provides a private, searchable online image repository with a 20-year lifespan.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/19/2016 via PR Newswire

BioClinica, Inc., acquired Clinverse, Inc.

See 236 Comparable Transactions
synopsis: Bioclinica, Inc., a specialty trials services and technology provider, announced it has acquired Clinverse, Inc. Clinverse automates and manages the entire financial lifecycle of global clinical trials for contract research organizations and pharmaceutical companies. Its suite of products pays clinical trial sites, vendors and their subjects.
buyer: BioClinica, Inc.
Bioclinica is a specialty services provider that utilizes expertise and technology to create clarity in the clinical trial process. Bioclinica is organized into three business segments to deliver focused service and multifaceted technologies. "
 target: Clinverse, Inc.
Clinverse, Inc. architected the industry's first automated financial management technology solution for clinical trials. Their solution standardizes clinical trial financial management for millions of financial transactions across the globe, including clinical site payments.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/21/2015 via PR Newswire

BioClinica, Inc., acquired Synowledge

See 153 Comparable Transactions
synopsis: BioClinica, Inc., a specialty clinical trials services and technology provider, announced that it has acquired Synowledge to expand into the drug safety and regulatory business process outsourcing market. Synowledge specializes in pharmacovigilance, regulatory affairs and information technology services to support biopharmaceutical companies.
buyer parent: JLL Partners
buyer: BioClinica, Inc.
BioClinica is a specialty clinical trials services provider that improves the development of new medical therapies by delivering expertise and technologies that enhance clinical research data and analytics, worldwide. "
 target: Synowledge
Synowledge is a specialized drug safety, regulatory affairs and IT services provider that assists and enables small, medium and large life sciences organizations to satisfy their global regulatory requirements.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/16/2014 via PR Newswire

BioClinica, Inc., acquired Blueprint Clinical

See 213 Comparable Transactions
synopsis: BioClinica®, Inc., a leading provider of eClinical Solutions for the Pharmaceutical Industry, has announced the acquisition of Blueprint Clinical, a fast-growing company offering ground-breaking technology and extensive expertise to drive successful Risk-Based Monitoring (RBM) strategies for clinical trials.
buyer parent: JLL Partners
buyer: BioClinica, Inc.
BioClinica, Inc. is a leading global provider of integrated clinical trial management technologies including eClinical solutions for clinical trial supply management, forecasting and optimization, electronic data capture, randomization, and clinical trial management. "
 target: Blueprint Clinical
Blueprint Clinical, Inc. creates Software-as-a-Service tools that help improve monitoring of clinical trials. Their first product, Blueprint Clinical Compass™, ultimately allows risk based monitoring implementation thereby improving quality and efficiency of clinical trials.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 2/11/2013 via BusinessWire

JLL Partners, will acquire BioClinica, Inc.

See 291 Comparable Transactions
synopsis: BioClinica®, Inc., a leading global provider of clinical trial management solutions and JLL Partners, Inc. announced that BC Acquisition Corp., which is a wholly-owned subsidiary of BioCore Holdings, Inc., each of which is an affiliate of JLL, has commenced a tender offer for all outstanding shares of BioClinica.
buyer: JLL Partners
JLL Partners is a leading New York-based private equity investment firm with approximately $4 billion of capital under management. JLL Partners’ investment philosophy is to partner with outstanding management teams and invest in companies that they can continue to grow into market leaders. "
 target: BioClinica, Inc.
BioClinica, Inc. is a leading global provider of integrated, technology-enhanced clinical trial management solutions. BioClinica solutions maximize efficiency and manageability throughout all phases of the clinical trial process.
price ($mm)[EV]
$114 [$105]
rev ($mm)
$79
EBITDA ($mm)
$10
EV / rev
1.4x
EV / EBITDA
10.5x
closed 3/26/2010 via BusinessWire

BioClinica, Inc., acquired TranSenda International, LLC.

See 291 Comparable Transactions
synopsis: BioClinica™, Inc., a global provider of clinical trial management services, announced its acquisition of substantially all of the assets of TranSenda International, LLC (“TranSenda”). TranSenda is a provider of clinical trial management software (CTMS) solutions and is a Microsoft Gold Certified Partner.
buyer: BioClinica, Inc.
BioClinica is a global clinical trials service organization, providing medical image management and eClinical services. This includes electronic data capture and clinical data management solutions to pharmaceutical, biotechnology and medical device companies and other organizations. "
 target: TranSenda International, LLC.
TranSenda is transforming the clinical trial environment by delivering solutions that address the underserved need to improve the "business-process" side of clinical trial operations. TranSenda provides modular software solutions for small to mid-sized companies engaged in clinical trials.
price ($mm)
$2.10
rev ($mm)
$1
EBITDA ($mm)
EV / rev
3.0x
EV / EBITDA
closed 9/1/2009 via BusinessWire

BioClinica, Inc., acquired CardioNow, Inc.

See 553 Comparable Transactions
synopsis: BioClinica, Inc., a global provider of clinical trial services, announced that it has acquired the CardioNow unit of Agfa HealthCare. With this addition, BioClinica now offers streamlined electronic transport solutions to facilitate the blinding, sharing, tracking and archiving of medical images for multi-center clinical trials.
buyer: BioClinica, Inc.
BioClinica is a global clinical trials service organization, providing medical image management and eClinical services. This includes electronic data capture and clinical data management solutions to pharmaceutical, biotechnology and medical device companies and other organizations. "
 target parent: Agfa Corp.
target: CardioNow, Inc.
CardioNow is an Image Management Service (IMS) that stores cardiac images, and transmits these images to cardiologists over the Internet as needed. The company also provides management consulting services for cardiologists.
price ($mm)
$1.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/25/2008 via BusinessWire

Bio-Imaging Technologies, Inc., acquired Phoenix Data Systems Inc.

See 156 Comparable Transactions
synopsis: Bio-Imaging Technologies, Inc. it has acquired privately held Phoenix Data Systems, Inc., a leading global clinical data services provider of electronic data capture services and a comprehensive array of broadly interoperable eClinical data solutions to the pharmaceutical and biotechnology industries.
buyer: Bio-Imaging Technologies, Inc.
BioClinica is a global clinical trials service organization, providing medical image management and eClinical services. This includes electronic data capture and clinical data management solutions to pharmaceutical, biotechnology and medical device companies and other organizations. "
 target: Phoenix Data Systems Inc.
Phoenix Data Systems delivers Full Service EDC, a unique combination of electronic data capture, interactive voice response, reporting, and data management services that give clinical data managers improved control to run well-managed studies.
price ($mm)[EV]
$19 [$18]
rev ($mm)
$12
EBITDA ($mm)
$1
EV / rev
1.8x
EV / EBITDA
15.4x
closed 7/9/2007 via BusinessWire

CapMed Corporation, acquired Juke Systems, Inc.

See 94 Comparable Transactions
synopsis: CapMed, a Division of Bio-Imaging Technologies, Inc. a leader in PHR solutions, has announced the acquisition of the patent-pending ICE First™ technology of Juke Systems, Inc. ICE First™ is an innovative mobile phone and web-based software tool for the storage and display of emergency medical information.
buyer parent: Bio-Imaging Technologies, Inc.
buyer: CapMed Corporation
CapMed, a division of Bio-Imaging Technologies, Inc., is the leading provider of interactive personal health management solutions for the healthcare and pharmaceutical industries. "
 target: Juke Systems, Inc.
Juke Systems, Inc., a dynamic new technology company, is focused on developing new and important ways to make mobile phones an even more significant part of everyday life. It starts with thinking about mobile phones in a whole new way, beyond just as a communication device.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/6/2007 via BusinessWire

Bio-Imaging Technologies, Inc., acquired Theralys SA

See 291 Comparable Transactions
synopsis: Bio-Imaging Technologies, Inc. announced the acquisition of Theralys SA. Theralys’ proprietary image processing software enables the introduction of quantitative imaging markers in the design of clinical trials for Neurovascular and CNS disorders.
buyer: Bio-Imaging Technologies, Inc.
BioClinica is a global clinical trials service organization, providing medical image management and eClinical services. This includes electronic data capture and clinical data management solutions to pharmaceutical, biotechnology and medical device companies and other organizations. "
 target: Theralys SA
Theralys, founded in 2001 and based in Lyon, France, operates an imaging core lab providing centralized blinded read services and image analysis. Their proprietary and validated software for clinical trials includes applications which enable the automated quantitation of various imaging parameters.
price ($mm)
$4.26
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/20/2019 via BNC Analysis

Monterro, acquired Viedoc

See 181 Comparable Transactions
synopsis: Monterro, the leading B2B software investor in the Nordics, has acquired a majority stake in Viedoc, a modern and sophisticated electronic data capture (EDC) system. Viedoc enables researchers to gather and evaluate clinical trial data more efficiently.
buyer: Monterro
Sweden-based Monterro is the leading B2B software investor in the Nordics, with a mission to turn software companies into market leaders. With operational experience from successfully developing and running companies, Monterro actively supports its portfolio companies in all aspects of growth. "
 target: Viedoc
Viedoc is a modern and sophisticated electronic data capture (EDC) system. Viedoc enables researchers to gather and evaluate clinical trial data more efficiently. Their powerful EDC system has been used in over 2000 trials in more than 75 countries in all therapeutic areas and clinical phases.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/24/2019 via BNC Analysis

TrialScope, acquired Clinical Trial Connect, LLC

See 177 Comparable Transactions
synopsis: TrialScope has acquired Clinical Trial Connect, a platform used by disease foundations and advocacy groups that connects their community members to relevant clinical trials. As part of the acquisition, founder Mike Wenger will share his technological expertise as part of the TrialScope team.
buyer: TrialScope
TrialScope is the global leader in clinical trial transparency and compliance. TrialScope's tools and systems enable their customers to improve their clinical trial process, mitigate registry and lifecycle risk, and ultimately achieve greater business success. "
 target: Clinical Trial Connect, LLC
Clinical Trial Connect is a platform used by disease foundations and advocacy groups that connects their community members to relevant clinical trials. Clinical Trial Connect was founded by Mike Wenger, who developed his own algorithm for matching patients to clinical trials.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/28/2019 via BNC Analysis

JLL Partners, Water Street Healthcare Partners, acquired THREAD Research

See 706 Comparable Transactions
synopsis: Water Street Healthcare Partners and JLL Partners have acquired Orange County, California-based THREAD, a provider of technology that enables virtual research approaches to modernize clinical studies and registries.
buyer: JLL Partners
buyer: Water Street Healthcare Partners
JLL Partners is a middle-market private equity firm with a 30-year track record of building and transforming businesses. Water Street is a strategic investor focused exclusively on healthcare. The firm has a strong record of building market-leading companies across key growth sectors in healthcare. "
 target: THREAD Research
THREAD is a virtual research platform used by biopharma, CROs, non-profit researchers, and life science organizations to capture global clinical study data in between, as well as during and instead of clinic visits.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/17/2019 via GlobeNewswire

Anju Software, will acquire OmniComm Systems, Inc.

See 460 Comparable Transactions
synopsis: Anju Software, a leading provider of comprehensive software solutions to the life sciences industry, will be acquiring OmniComm, a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services.
buyer parent: ABRY Partners, LLC
buyer: Anju Software
Anju Software, Inc. is a leading provider of comprehensive software solutions to the life sciences industry that provides an integrated platform spanning clinical operations, medical affairs, and commercial divisions, including integrated data intelligence. "
 target: OmniComm Systems, Inc. (OTCPK:OMCM:$24.62)
OmniComm is a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services to pharmaceutical and biotech companies, contract research organizations, and other clinical trial sponsors.
price ($mm)[EV]
$72 [$81]
rev ($mm)
$25
EBITDA ($mm)
$2
EV / rev
3.4x
EV / EBITDA
46.2x
announced 6/12/2019 via BusinessWire

Dassault Systemes, will acquire Medidata

See 229 Comparable Transactions
synopsis: Dassault Systèmes, a provider of solutions that transform the way products are designed, provided and supported, will be acquiring Medidata, a provider of a platform for clinical development, commercial, and real-world data.
buyer: Dassault Systemes (ENXTPA:DSY:$4,387.64)
Based in France, Dassault Systèmes provides clients with virtual universes to imagine sustainable innovations. Its solutions transform the way products are designed, produced, and supported. They foster social innovation, expanding possibilities for the virtual world to improve the real world. "
 target: Medidata (MDSO:$660.00)
Medidata is leading the digital transformation of life science, with a platform for clinical development, commercial, and real-world data. Powered by artificial intelligence, Medidata helps accelerate value, minimize risk and optimize outcomes.
price ($mm)[EV]
$5,825 [$5,822]
rev ($mm)
$660
EBITDA ($mm)
$81
EV / rev
8.8x
EV / EBITDA
72.2x
closed 4/10/2019 via BNC Analysis

TriNetX, acquired Custodix N.V.

See 255 Comparable Transactions
synopsis: TriNetX has acquired Custodix, a Belgian-based provider of clinical trial patient recruitment solutions. TriNetX is a global health research network that has revolutionised clinical research. Custodix is a provider of clinical trial patient recruitment solutions offering a range of solutions for ensuring compliance.
buyer: TriNetX
TriNetX is the global health research network enabling healthcare organizations, biopharma and CROs to collaborate, enhance trial design, accelerate recruitment and bring new therapies to market faster. "
 target: Custodix N.V.
Custodix is a Belgian provider of clinical trial patient recruitment solutions offering a range of solutions for ensuring compliance with European and US data protection legislation and security best practices.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/17/2018 via Company Press Release

Oracle Corporation, will acquire GoBalto

See 177 Comparable Transactions
synopsis: Oracle announced that it has entered into an agreement to acquire goBalto, which delivers leading cloud solutions to accelerate clinical trials by streamlining and automating the selection and set up of the best performing clinical research sites to conduct trials.
buyer: Oracle Corporation (ORCL:$39,766.00)
Oracle is a computer technology corporation developing and marketing computer hardware systems and enterprise software products. By eliminating complexity and simplifying IT, Oracle enables its customers to accelerate innovation and create added value for their customers. "
 target: GoBalto
goBalto, Inc. is an award winning, venture backed group of industry veterans that creates simple, focused software for the global drug trial industry. Its products offer drug trial sponsors and clinical research organizations the fastest, easiest possible way to start clinical studies on the web.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/18/2018 via PR Newswire

Genstar Capital LLC, acquired CRF Health

See 291 Comparable Transactions
synopsis: Genstar Capital, a leading investor in healthcare technology and services companies, is pleased to announce the acquisition of CRF Health, a global provider of eCOA and eConsent solutions for the life sciences industry. CRF Health's eSource solutions improve trial engagement by making the patient the center of the clinical trial process.
buyer: Genstar Capital LLC
Genstar Capital is a leading private equity firm that has been actively investing in high quality companies for more than 25 years. Based in San Francisco, Genstar works in partnership with its management teams to transform its portfolio companies into industry-leading businesses. "
 target parent: Vitruvian Partners LLP
target: CRF Health
CRF Health is the leading provider of patient-centered eSource technology solutions for the life sciences industry. CRF Health's TrialMax® platform consistently demonstrates the industry's highest data accuracy, patient and site compliance, and patient retention.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/21/2018 via BusinessWire

Anju Software, acquired Sylogent

See 177 Comparable Transactions
synopsis: Anju Software Inc., a life sciences software platform backed by Providence Equity Partners, has acquired Sylogent. Sylogent delivers cloud based state of the art software solutions and business services to the pharmaceutical industry focused specifically on the information required to bring a product to market.
buyer parent: Providence Equity Partners Inc.
buyer: Anju Software
Anju Software is a life sciences enterprise software platform focused on delivering exceptional business application solutions. Anju was founded by professionals with deep software domain expertise and a track record of building software platforms through strategic acquisitions and organic growth. "
 target: Sylogent
Sylogent delivers software and business services to the pharmaceutical industry focused specifically on the information required to bring a product to market. They ensure the timely completion of critical information, maximize compliance goals and reduce risk management liability.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/24/2017 via PR Newswire

Bracket Global, acquired mProve Health

See 534 Comparable Transactions
synopsis: Bracket, a leading clinical trial technology and specialty services provider, announced the strategic acquisition of mProve Health Inc., a leading provider of mobile technologies for life science companies. mProve Health offers regulatory compliant mobile solutions for patient recruitment and electronic clinical outcome assessments.
buyer parent: Genstar Capital LLC
buyer: Bracket Global
Bracket is a clinical trial technology and specialty services provider dedicated to helping biopharmaceutical sponsors and contract research organizations increase the power of their clinical research data by leveraging core competencies in Science, Technology, and Service. "
 target: mProve Health
mProve Health is a leading provider of mobile technologies for life science companies, helping them connect better with patients. The company offers industry-grade, regulatory compliant mobile solutions for patient recruitment, patient engagement, and electronic clinical outcome assessments.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/9/2017 via Company Press Release

PRA Health Sciences, acquired Parallel 6

See 177 Comparable Transactions
synopsis: HCAP Partners, a California-based mezzanine debt and private equity firm, announced that it has exited its investment in Parallel 6, Inc. (“P6”), a mobile clinical (“mClinical”) SaaS platform designed to recruit, enroll, engage and manage patients in clinical trials. P6 was sold to PRA Health Sciences, Inc.
buyer parent: Kohlberg Kravis Roberts & Co.
buyer: PRA Health Sciences (PRAH:$1,698.48)
PRA Health Sciences, Inc. is one of the world’s leading global CROs by revenue, providing outsourced clinical development services to the biotechnology and pharmaceutical industries. Since 2000, PRA has participated in approximately 3,500 clinical trials worldwide. "
 target parent: HCAP Partners
target: Parallel 6
Parallel 6’s technology digitally enrolls, engages and manages patients using mobile endpoints. Sponsors and clinical research organizations can connect directly with and manage patients anywhere in the world, seamlessly integrating into their daily lives.
price ($mm)
$40
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/31/2017 via BusinessWire

Anju Software, acquired ClinPlus

See 291 Comparable Transactions
synopsis: Anju Software Inc., a life sciences software platform backed by Providence Equity Partners, has acquired the assets of ClinPlus, a division of DZS Software Solutions, Inc. ClinPlus has a full suite of products used for the performance of clinical trials including EDC, IWRS, CTMS, eTMF, Data Management, Coding and SAS Reporting.
buyer parent: Providence Equity Partners Inc.
buyer: Anju Software
Anju Software is a life sciences enterprise software platform focused on delivering exceptional business application solutions with outstanding customer support. Anju was founded by a group of operating and investment professionals with deep software domain expertise. "
 target parent: DZS Software Solutions, Inc.
target: ClinPlus
ClinPlus, a division of DZS Software Solutions, Inc., has a full suite of products used for the performance of clinical trials including EDC, IWRS, CTMS, eTMF, Data Management, Coding and SAS Reporting.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/28/2017 via PR Newswire

Genstar Capital LLC, acquired Bracket Global

See 291 Comparable Transactions
synopsis: Genstar Capital, a middle-market private equity firm focused on investments in targeted segments of the healthcare, financial services, software, and industrial technology industries, announced that it has acquired Bracket, a leading scientifically-driven clinical trial technology and specialty services provider, from Parthenon Capital Partners.
buyer: Genstar Capital LLC
Genstar Capital is a San Francisco-based private equity firm that invests in leading middle-market companies. For over 20 years, they have utilized their deep industry knowledge and extensive executive networks to create value at their companies. "
 target parent: Parthenon Capital Partners
target: Bracket Global
Bracket is a specialty services provider dedicated to helping pharmaceutical sponsors and contract research organizations (CROs) achieve greater certainty and accurate outcomes in their clinical trials.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/16/2016 via BNC Analysis

DrugDev, acquired SecureConsent

See 177 Comparable Transactions
synopsis: DrugDev has acquired SecureConsent, a developer of mobile e-consent software. SecureConsent replaces the paper methods that have historically been used to secure informed consent from patients participating in drug studies with an e-consent method that uses tablets and other mobile devices.
buyer: DrugDev
DrugDev streamlines engagement among sponsors, CROs and doctors to advance the common goal of doing more trials. Through the creation of global, standardized processes DrugDev is consistently and efficiently transforming the way drug developers identify, engage and pay investigators. "
 target: SecureConsent
The software products developed by Secure Consent replace the paper methods that have historically been used to secure informed consent from patients participating in drug studies with an e-consent method that uses tablets and other mobile devices.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/18/2016 via BNC Analysis

PRA Health Sciences, acquired Nextrials, Inc.

See 291 Comparable Transactions
synopsis: PRA Health Sciences acquired all of the outstanding shares of Nextrials, Inc., a developer of web-based software which integrates electronic health records with clinical trials. Nextrials is an innovative, award-winning, leader in web-based software solutions for the clinical research industry.
buyer parent: Kohlberg Kravis Roberts & Co.
buyer: PRA Health Sciences (PRAH:$1,698.48)
At PRA Health Sciences, providing innovative solutions for their clients is what they do. They strive to move drug discovery forward, to help them develop life-saving and life- improving drugs. "
 target: Nextrials, Inc.
Nextrials is an innovative, award-winning, leader in web-based software solutions for the clinical research industry. Prism®, the Company’s clinical trial management software, brings together sophisticated trial management and electronic data capture (“EDC”) in a single package.
price ($mm)
$4.70
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/19/2016 via PR Newswire

BioClinica, Inc., acquired Clinverse, Inc.

See 236 Comparable Transactions
synopsis: Bioclinica, Inc., a specialty trials services and technology provider, announced it has acquired Clinverse, Inc. Clinverse automates and manages the entire financial lifecycle of global clinical trials for contract research organizations and pharmaceutical companies. Its suite of products pays clinical trial sites, vendors and their subjects.
buyer: BioClinica, Inc.
Bioclinica is a specialty services provider that utilizes expertise and technology to create clarity in the clinical trial process. Bioclinica is organized into three business segments to deliver focused service and multifaceted technologies. "
 target: Clinverse, Inc.
Clinverse, Inc. architected the industry's first automated financial management technology solution for clinical trials. Their solution standardizes clinical trial financial management for millions of financial transactions across the globe, including clinical site payments.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/17/2015 via PR Web

Aris Global LLC, acquired Medsight Solutions Inc.

See 255 Comparable Transactions
synopsis: ArisGlobal®, a leading provider of Cloud solutions to life sciences companies, is pleased to announce that it has acquired Medsight Solutions, including the revolutionary integrated risk management solution, Medsight Sapphire (now known as ArisGlobal agBalance™).
buyer: Aris Global LLC
For more than 20 years, ArisGlobal has led in the development of innovative software solutions for pharmacovigilance & safety, regulatory affairs, clinical research and medical information. "
 target: Medsight Solutions Inc.
Medsight Solutions Inc. is a life sciences solutions and professional services company with specialties in Clinical trial optimization, Benefit-risk assessment and Compliance monitoring.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/8/2015 via PE Hub

Vitruvian Partners LLP, acquired CRF Health

See 291 Comparable Transactions
synopsis: CRF Health, the leading global provider of eCOA solutions for the life sciences industry, announced a significant investment of funds managed and advised by Vitruvian Partners. The transaction establishes Vitruvian as majority shareholder of CRF Health.
buyer: Vitruvian Partners LLP
Vitruvian is an independent private equity firm which specialises in middle‐market buyouts, growth buyouts and growth capital investments. Vitruvian focuses on investing in industries such as information technology, healthcare, media, telecoms, financial services, business services, and leisure. "
 target: CRF Health
CRF Health is a leading provider of electronic Clinical Outcome Assessment (eCOA) solutions for global clinical trials. CRF Health’s TrialMax eCOA solutions consistently demonstrate the industry’s highest data accuracy, patient and site compliance, and patient retention.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/3/2014 via PR Newswire

PAREXEL International Corporation, acquired ClinIntel Ltd.

See 177 Comparable Transactions
synopsis: PAREXEL International Corporation, a global clinical research organization, announced that the Company has acquired all of the outstanding equity securities of privately-owned ClinIntel, a provider of clinical Randomization and Trial Supply Management (RTSM) services, based in the United Kingdom.
buyer: PAREXEL International Corporation (PRXL:$1,939.36)
PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and medical device industries. "
 target: ClinIntel Ltd.
Headquartered in the United Kingdom, ClinIntel is a provider of clinical Randomization and Trial Supply Management (RTSM) services. The company was founded in 2009, and works with biopharmaceutical companies and contract research organizations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/24/2014 via PR Newswire

The WIRB-Copernicus Group, acquired ePharmaSolutions, Inc.

See 177 Comparable Transactions
synopsis: WIRB-Copernicus Group (WCG), the world's largest provider of regulatory and ethical review services for clinical research, announced that ePharmaSolutions (ePS) has joined its group of companies. ePharmaSolutions is a leading provider of eClinical solutions and technology-enabled services that improve the conduct of clinical trials.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world's largest provider of regulatory and ethical solutions for clinical research, including Institutional Review Board (IRB) and Institutional Biosafety Committee (IBC) review. "
 target: ePharmaSolutions, Inc.
ePharmaSolutions is a leading provider of eClinical solutions and specialty clinical services that help improve the way trial sites are selected, trained, activated and managed to exceed enrollment goals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
Pages:  

Like MDDX


read more

MDDX

Aspyra, Inc.

Perspectum

Intelerad Medical Systems, Inc.

Kibi AB

M2S

DR Systems

STATServices

Vidistar, LLC

Forcare BV

Orchard Software Corporation

Aces Health

Medhub sp. z o.o.

Ignis Systems Corporation

invivodata, Inc.

Cloud 9 Software

PathCentral, Inc.

Evivar Medical Pty. Ltd.

Stanson Health

Proxsys, LLC

Pages:  
read more

MDDX

read more

MDDX

Clinverse, Inc.

Synowledge

Blueprint Clinical

BioClinica, Inc.

TranSenda International, LLC.

CardioNow, Inc.

Phoenix Data Systems Inc.

Juke Systems, Inc.

Theralys SA

read more

Viedoc

Clinical Trial Connect, LLC

THREAD Research

OmniComm Systems, Inc.

Medidata

Custodix N.V.

GoBalto

CRF Health

Sylogent

mProve Health

Parallel 6

ClinPlus

Bracket Global

SecureConsent

Nextrials, Inc.

Clinverse, Inc.

Medsight Solutions Inc.

CRF Health

ClinIntel Ltd.

ePharmaSolutions, Inc.

Pages:  
Geography
Matching Companies
Ticker: OM:RTC
 
 
 
 
 
 
 
 
Rethinking Care AB
Rethinking Care AB
Rethinking Care introduces a holistic concept in nursing & health, based on 3 interacting spheres of activity - "Software as a service", "Care as a service" & "Health as a service", based on a high level of competence in nursing & healthcare services as well as IT tools developed for health care.
year
2016
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: INOV
 
 
 
 
 
 
 
 
Inovalon, Inc.
Inovalon, Inc.
Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape.
year
2017
rev ($mm)
$449.36
EBITDA ($mm)
$75.91
EBIT ($mm)
$27.16
Net Income ($mm)
$34.82
Employees
2119
  • drill down
  • watch
Ticker: DB:COP
 
 
 
 
 
 
 
 
CompuGroup Medical AG
CompuGroup Medical AG
CompuGroup Medical is a leading global eHealth provider. Their software and communications solutions assist doctors, dentists, hospitals, pharmacists, associations, networks and other service providers with workflow, diagnosis and therapy.
year
2019
rev ($mm)
$879.35
EBITDA ($mm)
$200.48
EBIT ($mm)
$134.28
Net Income ($mm)
$82.69
Employees
5171
  • drill down
  • watch
Ticker: AIM:EMIS
 
 
 
 
 
 
 
 
EMIS Group PLC
EMIS Group PLC
Egton Medical Information Systems Ltd (EMIS) is the UK's market leading primary care software provider with more than 39 million patient records entrusted to its systems. Its aim is to make good quality, timely patient information available any time, any where through interoperable systems.
year
2018
rev ($mm)
$216.76
EBITDA ($mm)
$33.15
EBIT ($mm)
$21.39
Net Income ($mm)
$14.24
Employees
2046
  • drill down
  • watch
Ticker: EVH
 
 
 
 
 
 
 
 
Evolent Health
Evolent Health
Evolent partners with leading health systems to drive value-based care transformation. By providing clinical, analytical and financial capabilities, Evolent helps physicians and health systems achieve superior quality and cost results.
year
2016
rev ($mm)
$212.24
EBITDA ($mm)
($39.30)
EBIT ($mm)
($52.25)
Net Income ($mm)
Employees
946
  • drill down
  • watch
Ticker: TRHC
 
 
 
 
 
 
 
 
Tabula Rasa Healthcare
Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.
year
2018
rev ($mm)
$204.27
EBITDA ($mm)
$16.27
EBIT ($mm)
$1.63
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: MTBC
 
 
 
 
 
 
 
 
Medical Transcription Billing, Corp.
Medical Transcription Billing, Corp.
MTBC (Medical Transcription Billing, Corp) is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers, revenue cycle management companies and software vendors.
year
2019
rev ($mm)
$65.19
EBITDA ($mm)
$1.78
EBIT ($mm)
($1.62)
Net Income ($mm)
Employees
2400
  • drill down
  • watch
Ticker: TSXV:BIO
 
 
 
 
 
 
 
 
AioCare
AioCare
AioCare, formerly known as Biosign Technologies, develops and sells cloud-based healthcare software products that address the needs in clinic management, home care operations, health monitoring and virtual care management. Their cutting edge technology is transforming Healthcare delivery in Germany.
year
2015
rev ($mm)
$0.38
EBITDA ($mm)
($3.04)
EBIT ($mm)
($3.43)
Net Income ($mm)
$1.21
Employees
16
  • drill down
  • watch
Ticker: TSXV:MSD
 
 
 
 
 
 
 
 
Moseda Technologies, Inc.
Moseda Technologies, Inc.
Moseda Technologies is a software developer of secure mobile health and telemedicine solutions for the healthcare sector. Their SmartCare solution integrates the latest in mobile, wearables and SaaS technology to provide increased levels of efficiency and reduction in redundant administrative tasks.
year
2015
rev ($mm)
$0.02
EBITDA ($mm)
($1.86)
EBIT ($mm)
($1.86)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: OTCPK:IGMB.D
 
 
 
 
 
 
 
 
Clinigence, LLC.
Clinigence Holdings, a fully reporting, publicly-held company, is a leading healthcare information technology company providing an advanced, cloud-based platform that enables healthcare organizations to provide value-based care and population health management.
year
2018
rev ($mm)
$1.37
EBITDA ($mm)
($0.84)
EBIT ($mm)
($0.84)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: NMXS
 
 
 
 
 
 
 
 
Net Medical Xpress Solutions, Inc.
Net Medical Xpress Solutions, Inc.
Net Medical Xpress is a medical services company that provides clinical and diagnostic programs using advanced telemedicine solutions for hospitals. The company also develops FDA 510k-cleared and all-inclusive PACS products within the preventative, comprehensive, and critical healthcare segments.
year
2011
rev ($mm)
$3.21
EBITDA ($mm)
($0.20)
EBIT ($mm)
($0.21)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: ZMD
 
 
 
 
 
 
 
 
ZoomMed Inc.
ZoomMed Inc.
Zoommed Inc. develops and markets various computer applications for healthcare professionals in Canada. The company builds and operates the ZoomMed Communication Network, a clinical interoperable information exchange network between physicians and various other stakeholders of the healthcare sector.
year
2014
rev ($mm)
$6.08
EBITDA ($mm)
$2.65
EBIT ($mm)
$2.78
Net Income ($mm)
Employees
40
  • drill down
  • watch
Ticker: OTCPK:SYPT
 
 
 
 
 
 
 
 
Scrypt, Inc
Scrypt builds secure cloud-based workflow management and collaboration tools for regulated industries. They help businesses operating in regulated industries improve document workflow and regain valuable time while protecting business-critical information.
year
2009
rev ($mm)
$0.27
EBITDA ($mm)
($0.86)
EBIT ($mm)
($0.92)
Net Income ($mm)
Employees
7
  • drill down
  • watch
Ticker: ASX:VHT
 
 
 
 
 
 
 
 
Volpara Solutions
Volpara Solutions
Volpara Health Technologies Limited (VHT) is a New Zealand MedTech Software as a Service company. VHT is a leading provider of breast imaging analytics products that improve clinical decision-making and the early detection of breast cancer. Volpara Solutions is the sales and marketing arm of VHT.
year
2019
rev ($mm)
$3.29
EBITDA ($mm)
($7.96)
EBIT ($mm)
($8.08)
Net Income ($mm)
Employees
53
  • drill down
  • watch
Ticker: HAXS
 
 
 
 
 
 
 
 
Healthaxis, Inc.
Healthaxis, Inc.
HealthAxis Group is simultaneously the most experienced and modern SaaS-based supplier of benefit platform systems. The comprehensive suite offered by HealthAxis helps organizations address compliance, increase administrative efficiency, lower cost, and improve quality.
year
2007
rev ($mm)
$16.03
EBITDA ($mm)
$0.27
EBIT ($mm)
($0.86)
Net Income ($mm)
Employees
73
  • drill down
  • watch
Ticker: OTCPK:OMCM
 
 
 
 
 
 
 
 
OmniComm Systems, Inc.
OmniComm Systems, Inc.
OmniComm Systems, Inc. is a leading strategic software solutions provider to the life sciences industry. OmniComm is dedicated to helping the world’s pharmaceutical, biotechnology, diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments.
year
2019
rev ($mm)
$24.62
EBITDA ($mm)
$1.80
EBIT ($mm)
$1.31
Net Income ($mm)
$1.83
Employees
175
  • drill down
  • watch
Ticker: AIM:INS
 
 
 
 
 
 
 
 
Instem
Instem
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide.
year
2019
rev ($mm)
$30.83
EBITDA ($mm)
$4.12
EBIT ($mm)
$3.15
Net Income ($mm)
$2.27
Employees
238
  • drill down
  • watch
Ticker: DATA
 
 
 
 
 
 
 
 
DATATRAK International, Inc.
DATATRAK International, Inc.
DATATRAK International, Inc. is a worldwide ASP for the EDC industry. The Company provides a suite of software products supporting the use of DATATRAK EDC(TM) and related services to the pharmaceutical, biotechnology, and medical device industries.
year
2012
rev ($mm)
$9.72
EBITDA ($mm)
($1.37)
EBIT ($mm)
($1.53)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: SLP
 
 
 
 
 
 
 
 
Simulations Plus, Inc.
Simulations Plus, Inc.
Simulations Plus, Inc. is a premier developer of groundbreaking drug discovery and development simulation and modeling software that is licensed to and used in the conduct of drug research by major pharmaceutical, biotechnology, agrochemical, and food industry companies worldwide.
year
2019
rev ($mm)
$35.84
EBITDA ($mm)
$12.38
EBIT ($mm)
$11.28
Net Income ($mm)
$9.11
Employees
109
  • drill down
  • watch
Ticker: POAI
 
 
 
 
 
 
 
 
Predictive Oncology Inc.
Predictive Oncology Inc.
Predictive Oncology Inc. is a knowledge-driven company focused on applying artificial intelligence to personalized medicine and drug discovery. Predictive Oncology operates through five segments which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe.
year
2019
rev ($mm)
$1.38
EBITDA ($mm)
($13.26)
EBIT ($mm)
($13.71)
Net Income ($mm)
Employees
24
  • drill down
  • watch
Ticker: OMCL
 
 
 
 
 
 
 
 
Omnicell, Inc.
Omnicell, Inc.
Omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home.
year
2016
rev ($mm)
$692.62
EBITDA ($mm)
$62.94
EBIT ($mm)
$16.58
Net Income ($mm)
$0.60
Employees
2444
  • drill down
  • watch
Ticker: TRHC
 
 
 
 
 
 
 
 
Tabula Rasa Healthcare
Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.
year
2018
rev ($mm)
$204.27
EBITDA ($mm)
$16.27
EBIT ($mm)
$1.63
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: ZMD
 
 
 
 
 
 
 
 
ZoomMed Inc.
ZoomMed Inc.
Zoommed Inc. develops and markets various computer applications for healthcare professionals in Canada. The company builds and operates the ZoomMed Communication Network, a clinical interoperable information exchange network between physicians and various other stakeholders of the healthcare sector.
year
2014
rev ($mm)
$6.08
EBITDA ($mm)
$2.65
EBIT ($mm)
$2.78
Net Income ($mm)
Employees
40
  • drill down
  • watch
Ticker: ASX:MDR
 
 
 
 
 
 
 
 
MedAdvisor Limited
MedAdvisor Limited
MedAdvisor is a world class medication management platform focused on addressing the gap and burden of medication adherence. The highly automated Australian software system connects patients to their local pharmacy, providing them with real time access to their personal medication records.
year
2016
rev ($mm)
$1.05
EBITDA ($mm)
($2.13)
EBIT ($mm)
($2.15)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: MRCY
 
 
 
 
 
 
 
 
Mercury Computer Systems, Inc.
Mercury Computer Systems, Inc.
Mercury Computer Systems is the leading supplier of high-performance digital signal and image processing systems. These embedded computer systems transform streams of sensor data to visual information in real time for analysis and interpretation.
year
2011
rev ($mm)
$228.71
EBITDA ($mm)
$33.90
EBIT ($mm)
$25.55
Net Income ($mm)
$18.44
Employees
602
  • drill down
  • watch
Ticker: SYPT
 
 
 
 
 
 
 
 
Scrypt, Inc.
Scrypt, Inc.
Since 1998, Austin-based Scrypt, Inc. has been creating elegant document productivity tools for healthcare that eliminate manual processes and paper to save time and money. Scrypt has more than 30,000 customers across all 50 states.
year
2009
rev ($mm)
$0.27
EBITDA ($mm)
($0.85)
EBIT ($mm)
($0.91)
Net Income ($mm)
Employees
7
  • drill down
  • watch